The Israeli based drugmaker Teva is planning to start production in this summer at its production facility in Sajóbabony, Hungary. The company expanded the plant recently with an investment of HUF 2.3 bn. The pharmaceutical company is also based in Gödöllő, where it invested $110m in 2012 in a new production units. The company employs more than 3,000 people in the country. Teva has invested in Hungary HUF 350bn in the last twenty years.
